Insulin Cost Is a Key Campaign Issue for Biden

President Biden says lowering the cost of insulin for seniors is among his proudest domestic policy achievements. He now faces the challenge of selling it to Americans of all ages.

  • Share full article

Insulin Cost Is a Key Campaign Issue for Biden | INFBusiness.com

Kaye Peterson is one of the many Medicare recipients who directly benefit from one of President Biden’s proudest domestic policy accomplishments: capping the price of insulin for seniors.

Kaye Peterson, a 66-year-old retired librarian, is a direct beneficiary of one of President Biden’s proudest domestic policy achievements: lowering the cost of insulin for seniors.

A longtime diabetic, Ms. Peterson for much of her life spent around $300 a month on insulin to keep her blood sugar at a safe level. Now she pays $35 and uses the savings to help fund her room in an assisted living facility in Kentucky.

Mr. Biden’s policy, she said on a recent afternoon, was a “godsend” because it enshrines into law that Americans on Medicare, the federal health insurance program that covers people over 65 and some younger ones with certain disabilities, will not spend more than $35 per month on insulin.

As Mr. Biden makes his case for re-election, he regularly cites the cap on out-of-pocket costs for insulin on TikTok, in campaign advertisements and in speeches around the country. He sees the law as a crucial part of his record heading into the 2024 election, with bipartisan support and particular resonance for Americans with diabetes, one of the most common chronic diseases in America.

It also mirrors something of a generation gap in Mr. Biden’s base of support. Recent polling shows that voters older than 65, who usually vote Republican, are emerging as reliable supporters of Mr. Biden.

Younger voters, however, are showing signs of dissatisfaction. And some of those voters say they are still hoping for the reassurance of having the $35 limit written into law for them.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.

Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.

SKIP ADVERTISEMENT

Source: nytimes.com

Leave a Reply

Your email address will not be published. Required fields are marked *